The differences between batch processing and continuous manufacturing of biologics require a detailed understanding of material traceability and the effects of perturbations on material quality.
At the just completed BioProcess International Conference in Boston, a number of sessions focused on the Bioprocess 4.0 trend toward continuous bioprocessing operations. Akshat Mullerpatan, PhD, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback